CME Group Q3 revenue falls to $1.54 billion; net income slips to $908 million
CME Group reported third-quarter 2025 results, with total revenue of $1,537.6 million, down from $1,584.4 million a year earlier, and net income of $908.0 million, down from $912.8 million. Diluted earnings per share were $2.49 versus $2.50, while adjusted diluted EPS was $2.68, flat with the prior year. The headline GAAP measures declined year over year, which matters to shareholders because lower trading activity reduced revenue.
Key points
- Total revenue was $1,537.6 million for the quarter ended September 30, 2025, versus $1,584.4 million in the same quarter of 2024.
- Diluted EPS was $2.49 on a GAAP basis versus $2.50 a year earlier; adjusted diluted EPS was $2.68, unchanged from the prior year.
- Market data and information services revenue was a record $203 million; clearing and transaction fees were $1.2 billion.
- Quarterly average daily volume was 25,322 thousand contracts, down from 28,289 thousand in the third quarter of 2024.
The filing
Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 22, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.